$RNA SEC Filings

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

As previously disclosed in the Original Form 8-K, on October 7, 2026, the Company entered into a securities purchase agreement with selected investors that qualify as “accredited investors” (collectively, the “PIPE Investors”), as define...

This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of October 7, 2026, by and among Atrium Therapeutics, Inc., a Delaware corporation (the “Company”), and each of the entities listed on Exhibit A attached to this Agreement...

Gave up 11,216 shares to cover exercise price or tax ($100K)

Gave up 21,459 shares to cover exercise price or tax ($192K)

Gave up 22,812 shares to cover exercise price or tax ($204K)

Gave up 126,418 shares to cover exercise price or tax ($1.13M)

Gave up 2,375 shares to cover exercise price or tax ($21.3K)

Gave up 11,632 shares to cover exercise price or tax ($104K)

Gave up 6,742 shares to cover exercise price or tax ($60.3K)

Gave up 8,320 shares to cover exercise price or tax ($74.5K)